YGG / BTC

YGG / USDT

YGG / USDC

DEGO / USDT

RARE / BTC

RARE / USDC

RARE / USDT

RARE / TRY

NIL / BNB

DATA / BTC

TREE / BNB

ALICE / USDT

ALICE / TRY

ARPA / BTC

ARPA / TRY

ARPA / USDT

FF / TRY

FF / USDC

FF / USDT

FF / FDUSD

GUJARAT RAFFIA INDUST LTD

TREJHARA SOLUTIONS LTD

MASK INVESTMENTS LIMITED

E FACTOR EXPERIENCES LTD

RAMA PHOSPHATES LIMITED

ROCKINGDEALS CIRCU ECO L

GENESYS INTL CORPN LTD

SANDUR MANG & IRON ORES L

MINDTECK (INDIA) LIMITED

BEACON TRUSTEESHIP LTD

GLOBE INTL CARRIERS LTD

SKF INDIA LTD

KORE DIGITAL LIMITED

3I INFOTECH LTD

UNIVASTU INDIA LIMITED

SIDDHI COTSPIN LIMITED

DREAMFOLKS SERVICES LTD

KUNDAN EDIFICE LIMITED

SHREE OSFM E-MOBILITY LTD

KEYSTONE REALTORS LIMITED

Click here to get full coverage on Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet - Medical Dialogues

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet  Medical Dialogues

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet - Medical Dialogues

Click here to get full coverage on Alkem Laboratories Faces Evaluation Shift Amid Mixed Technical Indicators and Stakeholder Confidence Concerns - Markets Mojo

Alkem Laboratories Faces Evaluation Shift Amid Mixed Technical Indicators and Stakeholder Confidence Concerns  Markets Mojo

Alkem Laboratories Faces Evaluation Shift Amid Mixed Technical Indicators and Stakeholder Confidence Concerns - Markets Mojo

Click here to get full coverage on Why Analysts Are Bullish on Alkem Laboratories Limited Stock in the Next 5 Years - Relative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - earlytimes.in

Why Analysts Are Bullish on Alkem Laboratories Limited Stock in the Next 5 Years - Relative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy”  earlytimes.in

Why Analysts Are Bullish on Alkem Laboratories Limited Stock in the Next 5 Years - Relative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - earlytimes.in

Click here to get full coverage on PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent  VitalLaw.com

PATENT—Fed. Cir.: Alkem’s vancomycin oral solution did not infringe Azurity’s liquid antibiotic formulation patent - VitalLaw.com

Click here to get full coverage on Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot - Investing.com

Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot  Investing.com

Jefferies upgrades Alkem Laboratories stock rating to Buy on growth pivot - Investing.com

Click here to get full coverage on Alkem Laboratories Reports Strong Q1 FY26 Results with 11% Revenue Growth - TipRanks

Alkem Laboratories Reports Strong Q1 FY26 Results with 11% Revenue Growth  TipRanks

Alkem Laboratories Reports Strong Q1 FY26 Results with 11% Revenue Growth - TipRanks

Click here to get full coverage on Alkem Launches Pertuzumab Biosimilar In India - insights.citeline.com

Alkem Launches Pertuzumab Biosimilar In India  insights.citeline.com

Alkem Launches Pertuzumab Biosimilar In India - insights.citeline.com

Click here to get full coverage on Alkem's Enzene powers into US with $70 m investment - The Economic Times

Alkem's Enzene powers into US with $70 m investment  The Economic Times

Alkem's Enzene powers into US with $70 m investment - The Economic Times

Click here to get full coverage on Prosecution Disclaimer Alive and Well, Especially in Closed Claim - The National Law Review

Prosecution Disclaimer Alive and Well, Especially in Closed Claim  The National Law Review

Prosecution Disclaimer Alive and Well, Especially in Closed Claim - The National Law Review

Click here to get full coverage on Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4% - TradingView

Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%  TradingView

Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4% - TradingView

Click here to get full coverage on Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories  EY

Adroit Biomeds Shareholders divests 100% stake to Alkem Laboratories - EY

Click here to get full coverage on Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ET Pharma

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India  ET Pharma

Alkem launches Roche's breast cancer blockbuster biosimilar alternative in India - ET Pharma

Click here to get full coverage on Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks - NDTV Profit

Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks  NDTV Profit

Alkem Labs Q4 Review: Jefferies Cuts Estimates, Flags Execution Risks - NDTV Profit

Click here to get full coverage on Alkem Laboratories to Engage with Investors at Equirus Conference - TipRanks

Alkem Laboratories to Engage with Investors at Equirus Conference  TipRanks

Alkem Laboratories to Engage with Investors at Equirus Conference - TipRanks

Click here to get full coverage on Alkem Laboratories stock rating upgraded by BofA on margin improvement - Investing.com

Alkem Laboratories stock rating upgraded by BofA on margin improvement  Investing.com

Alkem Laboratories stock rating upgraded by BofA on margin improvement - Investing.com

Click here to get full coverage on Alkem launches breast cancer biosimilar in India - The Economic Times

Alkem launches breast cancer biosimilar in India  The Economic Times

Alkem launches breast cancer biosimilar in India - The Economic Times

Click here to get full coverage on Alkem expects Semaglutide trial read-out by year-end, targets first wave launch - ET Pharma

Alkem expects Semaglutide trial read-out by year-end, targets first wave launch  ET Pharma

Alkem expects Semaglutide trial read-out by year-end, targets first wave launch - ET Pharma

Click here to get full coverage on Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure - TipRanks

Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure  TipRanks

Alkem Laboratories to Reopen Trading Window Post Financial Results Disclosure - TipRanks

Click here to get full coverage on Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold?  The Economic Times

Alkem Laboratories shares drop 5% after Q4 results. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year - CNBC TV18

Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year  CNBC TV18

Alkem Labs Q1 Results: Shares jump 7% after every parameter rises from last year - CNBC TV18

Click here to get full coverage on Alkem vs Allchem: Pharma players in a legal tussle over who owns the name - Moneycontrol

Alkem vs Allchem: Pharma players in a legal tussle over who owns the name  Moneycontrol

Alkem vs Allchem: Pharma players in a legal tussle over who owns the name - Moneycontrol

Click here to get full coverage on Alkem launches Pertuza in India to treat HER2-positive breast cancer - Express Pharma

Alkem launches Pertuza in India to treat HER2-positive breast cancer  Express Pharma

Alkem launches Pertuza in India to treat HER2-positive breast cancer - Express Pharma

Click here to get full coverage on Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal - CNBC TV18

Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal  CNBC TV18

Alkem Laboratories promoter Jayanti Sinha likely to sell ₹825 crore stake via block deal - CNBC TV18

Click here to get full coverage on Alkem Laboratories shares surge 2.89% amid high volume; stock among top gainers on Nifty Midcap 150 - TradingView

Alkem Laboratories shares surge 2.89% amid high volume; stock among top gainers on Nifty Midcap 150  TradingView

Alkem Laboratories shares surge 2.89% amid high volume; stock among top gainers on Nifty Midcap 150 - TradingView

Click here to get full coverage on Alkem Labs transfers trade generics business to Alkem Wellness - Medical Dialogues

Alkem Labs transfers trade generics business to Alkem Wellness  Medical Dialogues

Alkem Labs transfers trade generics business to Alkem Wellness - Medical Dialogues

Click here to get full coverage on Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention? - simplywall.st

Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention?  simplywall.st

Do Alkem Laboratories' (NSE:ALKEM) Earnings Warrant Your Attention? - simplywall.st

Click here to get full coverage on Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands - Moneycontrol

Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands  Moneycontrol

Block deal worth Rs 825 crore in Alkem Labs may see 1.42 percent equity change hands - Moneycontrol

Click here to get full coverage on Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway  Medical Dialogues

Cybersecurity incident at Alkem Labs US arm, investigation underway - Medical Dialogues

Click here to get full coverage on Alkem Laboratories Shows Mixed Technical Trends Amidst Market Evaluation Revision - Markets Mojo

Alkem Laboratories Shows Mixed Technical Trends Amidst Market Evaluation Revision  Markets Mojo

Alkem Laboratories Shows Mixed Technical Trends Amidst Market Evaluation Revision - Markets Mojo

Click here to get full coverage on Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair  BioSpectrum India

Alkem introduces advanced ceramide-boosting product for skin barrier repair - BioSpectrum India

Click here to get full coverage on Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations - simplywall.st

Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations  simplywall.st

Alkem Laboratories First Quarter 2026 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller - Moneycontrol

Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller  Moneycontrol

Alkem Laboratories shares sink as 1.4% stake offloaded in block deal, promotor likely seller - Moneycontrol

Click here to get full coverage on Alkem Labs US arm hit by cyber fraud; financial loss under probe - CNBC TV18

Alkem Labs US arm hit by cyber fraud; financial loss under probe  CNBC TV18

Alkem Labs US arm hit by cyber fraud; financial loss under probe - CNBC TV18

Click here to get full coverage on Alkem Laboratories launches Pertuza for HER2-positive breast cancer treatment - CNBC TV18

Alkem Laboratories launches Pertuza for HER2-positive breast cancer treatment  CNBC TV18

Alkem Laboratories launches Pertuza for HER2-positive breast cancer treatment - CNBC TV18

Click here to get full coverage on Alkem Labs Senior Management Personnel Amit Ghare steps down - Medical Dialogues

Alkem Labs Senior Management Personnel Amit Ghare steps down  Medical Dialogues

Alkem Labs Senior Management Personnel Amit Ghare steps down - Medical Dialogues

Click here to get full coverage on Alkem Launches Breast Cancer Biosimilar in India - Rediff MoneyWiz

Alkem Launches Breast Cancer Biosimilar in India  Rediff MoneyWiz

Alkem Launches Breast Cancer Biosimilar in India - Rediff MoneyWiz

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Xeljanz XR Arthritis Drug - Bloomberg Law News

Click here to get full coverage on Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth - Business Standard

Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth  Business Standard

Alkem Labs Q1 profit rises 22% to ₹664 cr on India, overseas sales growth - Business Standard

Click here to get full coverage on Delhi High Court Bars Alchem International From Using ‘Alchem’; Clarifies Legal Principle of Acquiescence in Trademark Law - The Law Advice

Delhi High Court Bars Alchem International From Using ‘Alchem’; Clarifies Legal Principle of Acquiescence in Trademark Law  The Law Advice

Delhi High Court Bars Alchem International From Using ‘Alchem’; Clarifies Legal Principle of Acquiescence in Trademark Law - The Law Advice

Click here to get full coverage on Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore - CNBC TV18

Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore  CNBC TV18

Alkem Labs Block Deal: Promoter likely to have sold 1.4% equity worth over ₹800 crore - CNBC TV18

Click here to get full coverage on Alkem Laboratories Faces Mixed Technical Trends Amid Declining Promoter Confidence - Markets Mojo

Alkem Laboratories Faces Mixed Technical Trends Amid Declining Promoter Confidence  Markets Mojo

Alkem Laboratories Faces Mixed Technical Trends Amid Declining Promoter Confidence - Markets Mojo

Click here to get full coverage on Stocks to Watch Today: JBM Auto, Maruti, Alkem Labs, KEC International, Birla Corporation, Emkay Global,... - Moneycontrol

Stocks to Watch Today: JBM Auto, Maruti, Alkem Labs, KEC International, Birla Corporation, Emkay Global,...  Moneycontrol

Stocks to Watch Today: JBM Auto, Maruti, Alkem Labs, KEC International, Birla Corporation, Emkay Global,... - Moneycontrol

Click here to get full coverage on Alkem Labs completes acquisition of 100% stake in Adroit Biomed - Medical Dialogues

Alkem Labs completes acquisition of 100% stake in Adroit Biomed  Medical Dialogues

Alkem Labs completes acquisition of 100% stake in Adroit Biomed - Medical Dialogues

Click here to get full coverage on Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal - NDTV Profit

Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal  NDTV Profit

Alkem Promoter Jayanti Sinha To Sell 1.42% Stake Via Block Deal - NDTV Profit

Click here to get full coverage on Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal  Moneycontrol

Alkem Labs sees Rs 300 crore worth equity change hands in large deal - Moneycontrol

Click here to get full coverage on Alkem Laboratories Ltd gains for fifth straight session - Business Standard

Alkem Laboratories Ltd gains for fifth straight session  Business Standard

Alkem Laboratories Ltd gains for fifth straight session - Business Standard

Click here to get full coverage on Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug  Bloomberg Law News

Pfizer Sues Alkem to Block Copies of Blockbuster Xeljanz Drug - Bloomberg Law News

Click here to get full coverage on We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease - simplywall.st

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease  simplywall.st

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease - simplywall.st

Click here to get full coverage on Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics  Markets Mojo

Alkem Laboratories Shows Shift in Market Sentiment Amid Stable Financial Metrics - Markets Mojo

Click here to get full coverage on Alkem to buy two firms - The Times of India

Alkem to buy two firms  The Times of India

Alkem to buy two firms - The Times of India

Click here to get full coverage on Alkem Lab to Transfer Trade Generics Business to Alkem Wellness - scanx.trade

Alkem Lab to Transfer Trade Generics Business to Alkem Wellness  scanx.trade

Alkem Lab to Transfer Trade Generics Business to Alkem Wellness - scanx.trade

Click here to get full coverage on Alkem Labs transfers trade generics business to its subsidiary Alkem Wellness - CNBC TV18

Alkem Labs transfers trade generics business to its subsidiary Alkem Wellness  CNBC TV18

Alkem Labs transfers trade generics business to its subsidiary Alkem Wellness - CNBC TV18

Click here to get full coverage on Alkem Laboratories makes twin acquisitions - Mint

Alkem Laboratories makes twin acquisitions  Mint

Alkem Laboratories makes twin acquisitions - Mint

Click here to get full coverage on Alkem Laboratories launches Pertuza, a biosimilar drug to pertuzumab for treating HER2-positive breast cancer - Fortune India

Alkem Laboratories launches Pertuza, a biosimilar drug to pertuzumab for treating HER2-positive breast cancer  Fortune India

ALKEM

Price Chart

Key Statistics

Technicals

About ALKEM

Latest News

Alkem Labs Gets CDSCO Panel Nod for conducting Phase III study of Semaglutide tablet - Medical Dialogues

Alkem Laboratories Faces Evaluation Shift Amid Mixed Technical Indicators and Stakeholder Confidence Concerns - Markets Mojo

Why Analysts Are Bullish on Alkem Laboratories Limited Stock in the Next 5 Years - Relative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - earlytimes.in

Advanced Charts

Top Gainers

Top Losers